Quinolinic acid in the cerebrospinal fluid of children with symptomatic human immunodeficiency virus type 1 disease: relationships to clinical status and therapeutic response.

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Journal of Infectious Diseases

• Publication date

  1993-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/INFDIS/168.6.1380PMID 8245522
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A mechanism of quinolinic acid formation by brain in inflammatory neurological disease. Attenuation of synthesis from L-tryptophan by 6-chlorotryptophan and 4-chloro-3-hydroxyanthranilate.

  1993cited by this paper
• Mechanism of Delayed Increases in Kynurenine Pathway Metabolism in Damaged Brain Regions Following Transient Cerebral Ischemia

  1993cited by this paper
• Virus isolation and quinolinic acid in primary and chronic simian immunodeficiency virus infection

  1993cited by this paper
• 4-Chloro-3-hydroxyanthranilate, 6-chlorotryptophan and norharmane attenuate quinolinic acid formation by interferon-gamma-stimulated monocytes (THP-1 cells).

  1993cited by this paper
• Quantitation of human immunodeficiency virus, immune activation factors, and quinolinic acid in AIDS brains.

  1993cited by this paper
• The prevalence of computed tomographic abnormalities of the cerebrum in 100 consecutive children symptomatic with the human immune deficiency virus

  1993cited by this paper
• Kynurenine Pathway Enzymes in Brain: Responses to Ischemic Brain Injury Versus Systemic Immune Activation

  1993cited by this paper
• No Direct Neuronotoxicity by HIV-1 Virions or Culture Fluids from HIV-1-Infected T Cells or Monocytes

  1992cited by this paper
• Cytokine expression in the brain during the acquired immunodeficiency syndrome

  1992cited by this paper
• Progressive slowing of reaction time and increasing cerebrospinal fluid concentrations of quinolinic acid in HIV-infected individuals.

  1992cited by this paper
• Low levels of human immunodeficiency virus replication in the brain tissue of children with severe acquired immunodeficiency syndrome encephalopathy.

  1992cited by this paper
• Poliovirus induces indoleamine‐2,3‐dioxygenase and quinolinic acid synthesis in macaque brain

  1992cited by this paper
• Neopterin concentrations in pediatric human immunodeficiency virus infection as predictor of disease activity

  1992cited by this paper
• Human macrophages convert L-tryptophan into the neurotoxin quinolinic acid.

  1992cited by this paper
• Effects of immune activation on quinolinic acid and neuroactive kynurenines in the mouse.

  1992cited by this paper
• Relationship of neurologic status in macaques infected with the simian immunodeficiency virus to cerebrospinal fluid quinolinic acid and kynurenic acid.

  1992cited by this paper
• Relationship of cerebrospinal fluid immune activation associated factors to HIV encephalitis

  1992cited by this paper
• CD4 status and P24 antigenemia. Are they useful predictors of survival in HIV-infected children receiving antiretroviral therapy?

  1992cited by this paper
• Tumor necrosis factor-alpha in pediatric HIV-1 infection.

  1992cited by this paper
• Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease.

  1992cited by this paper
• Human immunodeficiency virus type 1–infected monocytic cells can destroy human neural cells after cell‐to‐cell adhesion

  1992cited by this paper
• Clinical pharmacology of 2',3'-dideoxyinosine in human immunodeficiency virus-infected children.

  1992cited by this paper
• Acquired immunodeficiency syndrome and the child's central nervous system.

  1992cited by this paper
• Inter-relationships between quinolinic acid, neuroactive kynurenines, neopterin and beta 2-microglobulin in cerebrospinal fluid and serum of HIV-1-infected patients.

  1992cited by this paper
• Tumor necrosis factor-α in pediatric HIV‐1 infection

  1992cited by this paper
• SOME BIOCHEMICAL STUDIES ON PSILOCYBIN AND PSILOCIN

  1992cited by this paper
• Human immunodeficiency virus-infected macrophages produce soluble factors that cause histological and neurochemical alterations in cultured human brains.

  1991cited by this paper
• Chronic effects of gamma-interferon on quinolinic acid and indoleamine-2,3-dioxygenase in brain of C57BL6 mice.

  1991cited by this paper
• Synergistic effects of HIV coat protein and NMDA receptor-mediated neurotoxicity.

  1991cited by this paper
• Serum tumor necrosis factor alpha, interleukin 1‐beta, p24 antigen concentrations and CD4+ cells at various stages of human immunodeficiency virus 1 infection in children

  1991cited by this paper
• Quinolinic acid is a potent lipid peroxidant in rat brain homogenates

  1991cited by this paper
• Relationship between interferon‐γ, indoleamine 2,3‐dioxygenase, and tryptophan catabolism

  1991cited by this paper
• Evidence for neurotoxic activity of tat from human immunodeficiency virus type 1

  1991cited by this paper
• Neopterin and interferon‐gamma in serum and cerebrospinal fluid of patients with HIV‐associated neurologic disease

  1991cited by this paper
• Dideoxyinosine in children with symptomatic human immunodeficiency virus infection.

  1991cited by this paper
• Quinolinic acid in cerebrospinal fluid and serum in HIV‐1 Infection: Relationship to clinical and neurological status

  1991cited by this paper
• Regional brain and cerebrospinal fluid quinolinic acid concentrations in Huntington's disease.

  1991cited by this paper
• Evidence for neurotoxic activity of tat from human immunodeficiency virus type 1.

  1991cited by this paper
• Picolinic acid, a catabolite of tryptophan, as the second signal in the activation of IFN-gamma-primed macrophages.

  1990cited by this paper
• Effect of continuous-infusion zidovudine therapy on neuropsychologic functioning in children with symptomatic human immunodeficiency virus infection.

  1990cited by this paper
• Quinolinic Acid Concentrations in Brain and Cerebrospinal Fluid of Patients with Intractable Complex Partial Seizures

  1990cited by this paper
• Treatment of human immunodeficiency virus-infected infants and young children with dideoxynucleosides.

  1990cited by this paper
• Secretion of neurotoxins by mononuclear phagocytes infected with HIV-1

  1990cited by this paper
• Central-nervous-system methyl-group metabolism in children with neurological complications of HIV infection.

  1990cited by this paper
• Pharmacokinetics of zidovudine administered intravenously and orally in children with human immunodeficiency virus infection.

  1989cited by this paper
• The excitatory amino acid receptors: their classes, pharmacology, and distinct properties in the function of the central nervous system.

  1989cited by this paper
• No changes in central quinolinic acid levels in Alzheimer's disease.

  1989cited by this paper
• Elevated neopterin and beta 2-microglobulin levels in blood and cerebrospinal fluid occur early in HIV-1 infection.

  1989cited by this paper
• Elevated serum levels of tumor necrosis factor are associated with progressive encephalopathy in children with acquired immunodeficiency syndrome.

  1989cited by this paper
• Cerebrospinal fluid beta 2 microglobulin in patients infected with human immunodeficiency virus.

  1989cited by this paper
• Cerebrospinal fluid ß2 microglobulin in patients infected with human immunodeficiency virus

  1989cited by this paper
• The pharmacokinetics of zidovudine administered by continuous infusion in children.

  1989cited by this paper
• Human immunodeficiency virus (HIV) infection and the nervous system

  1989cited by this paper
• Pediatric acquired immunodeficiency syndrome. Neurologic syndromes.

  1988cited by this paper
• Systemic Lipopolysaccharide and Pokeweed Mitogen Increase Quinolinic Acid Content of Mouse Cerebral Cortex

  1988cited by this paper
• Quantification of quinolinic acid in rat brain, whole blood, and plasma by gas chromatography and negative chemical ionization mass spectrometry: effects of systemic L-tryptophan administration on brain and blood quinolinic acid concentrations.

  1988cited by this paper
• Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide

  1988cited by this paper
• Expression of human immunodeficiency virus in cerebrospinal fluid of children with progressive encephalopathy

  1987cited by this paper
• Neurologic manifestations of human immunodeficiency virus infection in children.

  1986cited by this paper
• Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5

  1986cited by this paper
• HTLV-III infection in brains of children and adults with AIDS encephalopathy.

  1985cited by this paper
• Pharmacology and regional variations of quinolinic acid-evoked excitations in the rat central nervous system.

  1983cited by this paper
• Manual for the Bayley Scales of Infant Development

  1969cited by this paper

• Tryptophan catabolism via the kynurenine pathway regulates infection and inflammation: from mechanisms to biomarkers and therapies

  2024cites this paper
• Effects of tryptophan metabolism on the brain: From early development to Alzheimer's disease

  2022cites this paper
• The kynurenine pathway activities in a sub-Saharan HIV/AIDS population

  2015cites this paper
• Dysregulation of tryptophan metabolism in a sub-Saharan HIV/AIDS population

  2015cites this paper
• Metabolomics of cerebrospinal fluid from humans treated for rabies.

  2013cites this paper
• CHAPTER 21 – Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome in the Infant

  2011cites this paper
• Tryptophan, Neurodegeneration and HIV-Associated Neurocognitive Disorder

  2010cites this paper
• VIRAL INFECTION , GLUTAMATERGIC DEFICIT AND BEHAVIORAL CHANGES IN ANIMAL MODEL OF SCHIZOPHRENIA

  2009cites this paper
• Neurobehavioral and Neurodevelopmental Sequelae Associated with Pediatric HIV Infection

  2009cites this paper
• Involvement of quinolinic acid in aids dementia complex

  2009cites this paper
• Cell cycle proteins and the pathogenesis of HIV-1 encephalitis in the HAART era.

  2009cites this paper
• Youth with HIV/AIDS: Neurobehavioral Consequences

  2009cites this paper
• Neuropsychological outcome following intensity‐modulated radiation therapy for pediatric medulloblastoma

  2008cites this paper
• Cellular interplay between neurons and glia: toward a comprehensive mechanism for excitotoxic neuronal loss in neurodegeneration.

  2007cites this paper
• [Neuropsychological impairment in human immunodeficiency virus-positive children].

  2007cites this paper
• RELATIONSHIP BETWEEN SYSTEMIC AND CENTRAL NERVOUS SYSTEM MONOCYTE/MACROPHAGE INFECTION IN SIMIAN IMMUNODEFICIENCY VIRUS ENCEPHALITIS

  2006cites this paper
• Chapter 21 – Acquired Immunodeficiency Syndrome in the Infant

  2006cites this paper
• Efeito da administração intraestriatal aguda de ácido quinolínico sobre metabolismo energético em ratos jovens

  2006cites this paper
• Neurobehavioral function and assessment of children and adolescents with HIV-1 infection.

  2006cites this paper
• Cerebrospinal fluid proteomics and human immunodeficiency virus dementia: Preliminary observations

  2005cites this paper
• Coregistration of quantitative proton magnetic resonance spectroscopic imaging with neuropathological and neurophysiological analyses defines the extent of neuronal impairments in murine human immunodeficiency virus type‐1 encephalitis

  2005cites this paper
• Pocket proteins p107 and p130 exhibit increased expression in macrophages during SIV encephalitis

  2005cites this paper
• Mononuclear phagocytes in the pathogenesis of neurodegenerative diseases

  2005cites this paper
• Neuropsychopathology in the SIV/macaque model of AIDS.

  2005cites this paper
• CSF quinolinic acid levels are determined by local HIV infection: cross-sectional analysis and modelling of dynamics following antiretroviral therapy.

  2004cites this paper
• Assessment of the Macrophage Marker Quinolinic Acid in Cerebrospinal Fluid after Pediatric Traumatic Brain Injury: Insight into the Timing and Severity of Injury in Child Abuse

  2004cites this paper
• Psychotropic viruses.

  2004cites this paper
• Neurologic aspects of HIV infection in infants and children: Therapeutic approaches and outcome

  2003cites this paper
• Tryptophan Metabolites and Brain Disorders

  2003cites this paper
• Macrophages relate presynaptic and postsynaptic damage in simian immunodeficiency virus encephalitis.

  2002cites this paper
• Cell Cycle Proteins Exhibit Altered Expression Patterns in Lentiviral-Associated Encephalitis

  2002cites this paper
• Neuropsychological consequences of HIV in children: a review of current literature.

  2002cites this paper
• Glutamate is a mediator of neurotoxicity in secretions of activated HIV-1-infected macrophages.

  2001cites this paper
• Paradigms for behavioral assessment of viral pathogenesis.

  2001cites this paper
• Elevated cerebrospinal fluid quinolinic acid levels are associated with region-specific cerebral volume loss in HIV infection.

  2001cites this paper
• Endogenous neurotoxins from tryptophan.

  2001cites this paper
• Kynurenines in the CNS: from endogenous obscurity to therapeutic importance.

  2001cites this paper
• Abnormally increased semantic priming in children with symptomatic HIV-1 disease: Evidence for impaired development of semantics?

  2001cites this paper
• Children and adolescents living with HIV and AIDS: a review.

  2000cites this paper
• Nutritional Contributions to the CNS Pathophysiology of HIV-1 Infection and Implications for Treatment

  2000cites this paper
• HIV-1 Infection Spectrum Disease

  2000cites this paper
• Role of immune-derived diffusible mediators in AIDS-associated neurological disorders.

  2000cites this paper
• Cerebrospinal fluid studies in children with cerebral malaria: an excitotoxic mechanism?

  2000cites this paper
• Parallel Decrease in Neurotoxin Quinolinic Acid and Soluble Tumor Necrosis Factor Receptor p75 in Serum during Highly Active Antiretroviral Therapy of HIV Type 1 Disease

  2000cites this paper
• Induction of cell-cycle regulators in simian immunodeficiency virus encephalitis.

  2000cites this paper
• Inflammatory cytokines and HIV-1-associated neurodegeneration: oncostatin-M produced by mononuclear cells from HIV-1-infected individuals induces apoptosis of primary neurons.

  1999cites this paper
• Central Nervous System Abnormalities in Pediatric Human Immunodeficiency Virus Infection

  1999cites this paper
• Immune-derived cytokines in the nervous system: epigenetic instructive signals or neuropathogenic mediators?

  1999cites this paper
• The SIV‐infected rhesus monkey model for HIV‐associated dementia and implications for neurological diseases

  1999cites this paper
• The neuropathogenesis of HIV-1 infection.

  1999cites this paper
• Plasma Pyridoxine Deficiency Is Related to Increased Psychological Distress in Recently Bereaved Homosexual Men

  1998cites this paper
• Sources of the neurotoxin quinolinic acid in the brain of HIV-1-infected patients and retrovirus-infected macaques.

  1998cites this paper
• HPLC analysis of quinolinic acid, a NAD biosynthesis intermediate, after fluorescence derivatization in an aqueous matrix.

  1998cites this paper
• Inhibition of group B streptococcal growth by IFN gamma-activated human glioblastoma cells.

  1998cites this paper
• Sources of the neurotoxin quinolinic acid in the brain of HIV‐1‐infected patients and retrovirus‐infected macaques

  1998cites this paper
• Receptive and expressive language function of children with symptomatic HIV infection and relationship with disease parameters: a longitudinal 24‐month follow‐up study

  1997cites this paper
• Neuropsychological and Neurobehavioral Sequelae Associated with Pediatric HIV Infection

  1997cites this paper
• Biochemical characteristics of gamma-glutamyl transpeptidase in capillaries from entorhinohippocampal complex of quinolinate-lesioned rat brain.

  1997cites this paper
• Prospective study of neurological responses to treatment with macrophage‐targeted glucocerebrosidase in patients with type 3 Gaucher's disease

  1997cites this paper
• Risk and resilience in the cognitive functioning of children born to HIV-1-infected mothers: a preliminary report.

  1997cites this paper
• The kynurenine pathway and neurologic disease. Therapeutic strategies.

  1996cites this paper
• Quinolinic Acid Levels in a Murine Retrovirus‐Induced Immunodeficiency Syndrome

  1996cites this paper
• Neurobehavioral manifestations of symptomatic HIV-1 disease in children: can nutritional factors play a role?

  1996cites this paper
• Vertical human immunodeficiency virus-1 infection: Involvement of the central nervous system and treatment

  1996cites this paper
• Randomized study of the tolerance and efficacy of high- versus low-dose zidovudine in human immunodeficiency virus-infected children with mild to moderate symptoms (AIDS Clinical Trials Group 128). Pediatric AIDS Clinical Trials Group.

  1996cites this paper
• The effect of quinolinate on rat brain lipid peroxidation is dependent on iron.

  1996cites this paper
• The Kynurenine Pathway and Neurologic Disease

  1996cites this paper
• Impairment of expressive behavior in pediatric HIV-infected patients with evidence of CNS disease.

  1996cites this paper
• Human fetal glial cells constitutively produce HIV-inducing cytokines.

  1996cites this paper
• Increased human immunodeficiency virus (HIV) type 1 DNA content and quinolinic acid concentration in brain tissues from patients with HIV encephalopathy.

  1995cites this paper
• Striatal Met‐Enkephalin and Substance P Levels Are Decreased in Mice Infected with the LP‐BM5 Murine Leukemia Virus

  1995cites this paper
• Quantification of Quinolinic Acid Metabolism by Macrophages and Astrocytes

  1995cites this paper
• NEUROLOGIC AND PSYCHIATRIC MANIFESTATIONS OF PEDIATRIC AIDS

  1995cites this paper
• Adhesion of Human Neuroblasts to HIV-1 tat

  1995cites this paper
• Markers and determinants of disease progression in children with HIV infection. The Pediatric AIDS Siena Workshop II.

  1995cites this paper
• Quinolinic acid in tumors, hemorrhage and bacterial infections of the central nervous system in children.

  1995cites this paper
• White matter changes on ct brain scan are associated with neurobehavioral dysfunction in children with symptomatic HIV disease

  1995cites this paper
• Quantitative neuropathologic assessment of HIV-1 encephalitis.

  1995cites this paper
• Antiretroviral therapy for infection due to human immunodeficiency virus in children.

  1994cites this paper
• The neuropathogenesis of HIV‐1 infection

  1994cites this paper
• Antiretroviral therapy for infection due to human immunodeficiency virus in children.

  1994cites this paper
• A mechanism of quinolinic acid formation by brain in inflammatory neurological disease. Attenuation of synthesis from L-tryptophan by 6-chlorotryptophan and 4-chloro-3-hydroxyanthranilate.

  1993cites this paper
• Human microglia convert l-tryptophan into the neurotoxin quinolinic acid.

  1992cites this paper
• Neurobiology of Simian and Feline Immunodeficiency Virus Infections

  1991cites this paper